Otros idiomas NovAccess Global Inc.

Acciones

XSNX

US67001N1072

Mercado cerrado - OTC Markets Otros sitios de cotización 21:59:58 10/05/2024			Varia. Cinco días.	Varia. 1 de enero.
0,007 ^USD	+16,67 %		+7,69 %	-65,17 %

27/02	NovAccess Global Inc. informa de los resultados del primer trimestre finalizado el 31 de diciembre de 2023	CI
09/02	NovAccess Global Inc. presenta los resultados del ejercicio cerrado el 30 de septiembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

NovAccess Global : Announces New License to Advance its Immunotherapy Platform	30/04
NovAccess Global Inc. announced that it has received $0.0265 million in funding from AJB Capital Investments LLC	29/04
NovAccess Global Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	27/02
NovAccess Global Inc. announced that it has received $0.1 million in funding from AJB Capital Investments LLC	27/02
NovAccess Global Inc. Reports Earnings Results for the Full Year Ended September 30, 2023	09/02
NovAccess Global Announces $10.7 Million Financing	03/01
NovAccess Global Inc. to Present at the December 7th Virtual Investor Summit	01/12
NovAccess Global Inc. Appoints Roscoe M. Moore, Jr. to Scientific Advisory Board	10/11
NovAccess Global Inc. announced that it expects to receive $10.68 million in funding from Sumner Capital Pty Ltd.	01/09/23
NovAccess Global Inc. announced that it expects to receive $0.055 million in funding	16/08/23
NovAccess Global Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	11/08/23
NovAccess Global Partners with BCN Biosciences to Expand Immunotherapy Platform	28/07/23
NovAccess Global Inc. Partners with BCN Biosciences to Expand Immunotherapy Platform	27/07/23
NovAccess Global : to Participate in National Brain Tumor Society’s Annual Glioblastoma Awareness Day	13/07/23
NOVACCESS GLOBAL INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	23/06/23
NovAccess Global Inc. announced that it has received $0.055 million in funding from 1800 Diagonal Lending, LLC	20/06/23
NovAccess Global Partners with CKN Ventures to Expand its New AI-driven Precision Medicine Division	16/06/23
NOVACCESS GLOBAL INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	12/06/23
NovAccess Global Inc. Enters into a Letter Agreement with AJB Capital Investments, LLC	12/06/23
NovAccess Global Inc. Launches Precision Medicine Division Using AI, Big Data and Predictive Technologies to Accelerate Personalised Healthcare Therapies	01/06/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas NovAccess Global Inc.

Acciones

XSNX

US67001N1072

Otros idiomas

Filtros